TAG:
aco
PathSOURCE Is Newest Pathology Consolidator
By Robert Michel | From the Volume V No. 15 – November 9, 1998 Issue
CEO SUMMARY: Based in New York, PathSOURCE becomes the newest pathology network and services company to hit the market. PathSOURCE’s organizers want to link “best in class” dermatopathologists and academic pathology subspecialists to compete for outreach pathology specimens. PathSOU…
“September 28, 1998 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume V No. 13 – September 28, 1998 Issue
Just days ago, Bayer AG announced one of the largest drug-discovery alliances ever created. Bayer will pay Millennium Pharmaceuticals, Inc. $465 million. In return, over a six-year period, Millennium will use genomics techniques to identify cures for various diseases…
Pathologists, Clin Labs, Pharmacogenomics & PPMs
By R. Lewis Dark | From the Volume V No. 12 – September 8, 1998 Issue
AT MY AGE, I AM LEARNING THAT PEOPLE TEND TO HOLD ONE OF TWO OPINIONS about me. It seems that I can frequently be considered a doddering old fool who is totally unhip (although I recall an even earlier generation calling it “unhep”). On the other hand, there are those who grant me great respect. …
Pharmacogenomics Is The Coming Wave
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
CEO SUMMARY: It may be gloom and doom today in the clinical laboratory industry, but long term prospects for diagnostic testing are brightening. Increased understanding of human genetics drives new discoveries about how and why the same drug affects individuals differently. Biotech compan…
Genetic Testing Almost Accented In Market Place
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
CEO SUMMARY: Advances in molecular and genetic science have generated the first generation of diagnostic assays for clinical use. As these assays reach the public, acceptance is not immediate. Obstacles are many: ethical, cultural, clinical, and economic. Oncormed’s experience during th…
AccuMed, AutoCyte, Cytyc, MorphoMetrix, Neuromedical, NeoPath
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
Automated Cytology Update As predicted by THE DARK REPORT, the field of automated cytology has become a boiling pot, filled with controversy and change. Profits are meager. As we expected, the major issue revolves around the cost of this enhanced technology versus the measurable…
Unrealized Gains Targeted By Premier’s Lab Initiative
By Robert Michel | From the Volume V No. 9 – July 6, 1998 Issue
CEO SUMMARY: In part one of this exclusive interview, Premier’s John Biggers described the reasons why the 1,700 hospital consortium developed a strategic services program for clinical laboratories. In this final installment, Biggers provides insight as to how the program will work and …
Consolidation Within the Auto Industry
By R. Lewis Dark | From the Volume IV No. 17 – December 8, 1997 Issue
As our system of healthcare evolves in this country, I am continually amazed at how many market dynamics we share with other industries. Take the issue of too many hospital beds and too much laboratory capacity. With inpatient utilization declining, with laboratory reimbursement shrinking, both hospi…
Regional Tox Laboratory Shows Sustained Growth
By Robert Michel | From the Volume IV No. 16 – November 17, 1997 Issue
CEO SUMMARY: Over a three-year period, this regional substance abuse laboratory has shown dramatic growth in revenue and operating profits. Strong leadership combined with good implementation skills fuel this lab’s success. HERE’S ANOTHER QUIET SUCCESS story about a reg…
Visualize Your Laboratory’s Future
By R. Lewis Dark | From the Volume IV No. 7 – May 12, 1997 Issue
Many of you who read this will be in attendance at the second annual Executive War College on Medical Laboratory Networking in New Orleans. The case studies of laboratory consolidation and regional laboratory networks that you’ll hear provide compelling evidence that laboratories must chan…
CURRENT ISSUE

Volume XXXII, No. 7 – May 12, 2025
Economic, Tech changes drive lab concerns, The Dark Report provides insights from the Executive War College speakers about how clinical labs can use business strategies and tactics to handle the new tariffs, future regulations, and artificial intelligence (AI). Also, this issue provides guidance on how labs and pathologists should prepare for payer audits.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized